Pooled analysis across multiple countries of real-world effectiveness and safety from ongoing post-marketing observational studies
Latest Information Update: 13 Sep 2019
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 13 Sep 2019 New trial record